Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 28, 2023

BUY
$2.95 - $4.44 $41 - $62
14 Added 0.11%
12,538 $49,000
Q1 2023

May 10, 2023

BUY
$2.94 - $4.18 $36,820 - $52,350
12,524 New
12,524 $41,000
Q1 2022

May 16, 2022

SELL
$3.58 - $4.98 $39,222 - $54,560
-10,956 Closed
0 $0
Q4 2021

Feb 23, 2022

BUY
$4.17 - $7.09 $45,686 - $77,678
10,956 New
10,956 $53,000

Others Institutions Holding MESO

About MESOBLAST LTD


  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $1.57B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Vanguard Personalized Indexing Management, LLC Portfolio

Follow Vanguard Personalized Indexing Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.